Vermont Cancer Center at Fletcher Allen Health Care — Burlington, Vermont

Vermont Cancer Center at Fletcher Allen Health Care is a clinical research site located in Burlington, Vermont, United States 05401.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Vermont Cancer Center at Fletcher Allen Health Care has participated in 2 clinical trials.

Therapeutic areas: Thyroid Cancer, Cancer.

Sponsors: Exelixis, Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vermont Cancer Center at Fletcher Allen Health Care?

Vermont Cancer Center at Fletcher Allen Health Care has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vermont Cancer Center at Fletcher Allen Health Care conducted?

Vermont Cancer Center at Fletcher Allen Health Care has 2 clinical trials on record. Their work covers Thyroid Cancer, Cancer.

Is Vermont Cancer Center at Fletcher Allen Health Care accredited by Crixeo Health?

Vermont Cancer Center at Fletcher Allen Health Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vermont Cancer Center at Fletcher Allen Health Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.